Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DeGraaf

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 1, 1986
An orally active inhibitor of reninD T Pals, S Thaisrivongs, J A Lawson, et al.
Physical Review. C, Nuclear Physics|July 1, 1994
Rotational structures in 106Sn: A new form of band termination?Wadsworth, Andrews, Beausang, et al.
Journal of Medicinal Chemistry|February 1, 1991
Renin inhibitory peptides. Incorporation of polar, hydrophilic end groups into an active renin inhibitory peptide template and their evaluation in a human renin infused rat model and in conscious sodium-depleted monkeysS Thaisrivongs, D T Pals, D W DuCharme, et al.
Physical Review. C, Nuclear Physics|June 1, 1996
Smooth band termination in 108SnWadsworth, Beausang, Cromaz, et al.
Reproduction (Cambridge, England)|April 13, 2011
The cholinergic system in rat testis is of non-neuronal originS U Schirmer, I Eckhardt, H Lau, et al.
The Clinical Neuropsychologist|November 30, 2019
Preliminary examination of the validity of the NIH toolbox cognition battery in treatment-resistant psychosisBriana D Cassetta, Mahesh Menon, Prescilla B Carrion, et al.
Bioorganic & Medicinal Chemistry|December 1, 1994
Appraisal of a glycopeptide cloaking strategy for a therapeutic oligopeptide: glycopeptide analogs of the renin inhibitor ditekirenA W Harrison, J F Fisher, D M Guido, et al.
Physical Review. C, Nuclear Physics|August 1, 1994
Deformed intruder band in 112Te: First evidence for rotational behavior in the tellurium isotopesPaul, Beausang, Forbes, et al.
Plos One|April 11, 2020
Evaluation of radiation treatment volumes for unknown primaries of the head and neck in the era of FDG PETAlexis Platek, Michael Mix, Varun Chowdhry, et al.
Ophthalmology|March 4, 2023
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year ResultsCarl Regillo, Brian Berger, Logan Brooks, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Hypertension (Dallas, Tex. : 1979)|December 1, 1986
An orally active inhibitor of reninD T Pals, S Thaisrivongs, J A Lawson, et al.
Physical Review. C, Nuclear Physics|July 1, 1994
Rotational structures in 106Sn: A new form of band termination?Wadsworth, Andrews, Beausang, et al.
Journal of Medicinal Chemistry|February 1, 1991
Renin inhibitory peptides. Incorporation of polar, hydrophilic end groups into an active renin inhibitory peptide template and their evaluation in a human renin infused rat model and in conscious sodium-depleted monkeysS Thaisrivongs, D T Pals, D W DuCharme, et al.
Physical Review. C, Nuclear Physics|June 1, 1996
Smooth band termination in 108SnWadsworth, Beausang, Cromaz, et al.
Reproduction (Cambridge, England)|April 13, 2011
The cholinergic system in rat testis is of non-neuronal originS U Schirmer, I Eckhardt, H Lau, et al.
The Clinical Neuropsychologist|November 30, 2019
Preliminary examination of the validity of the NIH toolbox cognition battery in treatment-resistant psychosisBriana D Cassetta, Mahesh Menon, Prescilla B Carrion, et al.
Bioorganic & Medicinal Chemistry|December 1, 1994
Appraisal of a glycopeptide cloaking strategy for a therapeutic oligopeptide: glycopeptide analogs of the renin inhibitor ditekirenA W Harrison, J F Fisher, D M Guido, et al.
Physical Review. C, Nuclear Physics|August 1, 1994
Deformed intruder band in 112Te: First evidence for rotational behavior in the tellurium isotopesPaul, Beausang, Forbes, et al.
Plos One|April 11, 2020
Evaluation of radiation treatment volumes for unknown primaries of the head and neck in the era of FDG PETAlexis Platek, Michael Mix, Varun Chowdhry, et al.
Ophthalmology|March 4, 2023
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year ResultsCarl Regillo, Brian Berger, Logan Brooks, et al.
Pageof 8